ACTINIUM PHARMACEUTICALS INC (ATNM)
US00507W2061 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 78.66M | 76.68M | 108.91M | 77.83M | 63.56M | |||
| Other Current Assets | 860.00K | 1.59M | 2.03M | 1.92M | 1.36M | |||
| Total Current Assets | 79.52M | 78.26M | 110.94M | 79.75M | 64.92M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.27M | 2.87M | 2.95M | 639.00K | 1.03M | |||
| Other Non-Current Assets | 322.00K | 313.00K | 302.00K | 0.00 | 441.00K | |||
| Total Non-Current Assets | 2.59M | 3.18M | 3.25M | 639.00K | 1.47M | |||
| TOTAL ASSETS | 82.11M | 81.44M | 114.19M | 80.39M | 66.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 11.00K | 11.00K | 4.00K | 62.00K | 85.00K | |||
| Accrued Expenses | 549.00K | 530.00K | 494.00K | 245.00K | 342.00K | |||
| Accounts Payable | 7.20M | 7.95M | 10.13M | 5.54M | 4.34M | |||
| Other Current Liabilities | N/A | N/A | 0.00 | 998.00K | N/A | |||
| Total Current Liabilities | 7.75M | 8.49M | 10.63M | 6.84M | 4.77M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 12.00K | 19.00K | 0.00 | 3.00K | 66.00K | |||
| Other Non-Current Liabilities | 36.14M | 36.55M | 37.08M | 0.00 | 245.00K | |||
| Total Non-Current Liabilities | 36.15M | 36.57M | 37.08M | 3.00K | 311.00K | |||
| TOTAL LIABILITIES | 43.91M | 45.07M | 47.71M | 6.84M | 5.08M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -369.17M | -337.58M | -288.76M | -255.75M | -230.97M | |||
| Additional Paid In Capital | 407.35M | 373.93M | 355.22M | 329.27M | 292.27M | |||
| Common Shares | 31.00K | 28.00K | 26.00K | 22.00K | 18.00K | |||
| Shares Outstanding | 31.20M | 27.63M | 25.67M | 22.14M | 17.53M | |||
| Tangible Book Value per Share | 1.22 | 1.32 | 2.59 | 3.32 | 3.50 | |||
| Total Shareholders' Equity | 38.21M | 36.38M | 66.48M | 73.55M | 61.32M | |||
| TOTAL LIABILITIES AND EQUITY | 82.11M | 81.44M | 114.19M | 80.39M | 66.40M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.00 | N/A | 0.00 | 0.00 | |||
| Current Ratio | 10.25 | 9.21 | 10.44 | 11.66 | 13.62 | |||
| Return On Assets (ROA) | -49.83% | -59.94% | -28.91% | -30.82% | -33.46% | |||
| Return On Equity (ROE) | -107.08% | -134.19% | -49.66% | -33.69% | -36.23% | |||
All data in USD , ROIC based on taxRate of 0.21